Medicine evaluation figures

The European Medicines Agency (EMA) publishes information on the volume and outcome of marketing authorisation and post-authorisation applications for human and veterinary medicines that it evaluates.

The documents on this page contain factual information on medicines evaluation, presented on an annual and monthly basis.

Please ntoe that the monthly figures listed on this page only cover human medicines. For monthly evaluation figures on veterinary medicines, see the monthly reports of the Committee for Medicinal Products for Veterinary Use (CVMP) onCVMP: Agendas, minutes and reports.

For commentaries and analysis, see the Agency's annual reports.

For the main outcomes of the monthly plenary meetings of the Agency's seven scientific committees, see Committee highlights.

Annual medicines highlights (2015-2020)

Human medicines (updated)

In 2020, EMA recommended for authorisation:

  • 97 new medicines
  • 39 new active substances

Human medicines highlights 2020 - infographic with figures

Veterinary medicines (updated)

In 2020, EMA recommended for authorisation:

  • 20 new medicines
  • 10 new active substances

Veterinary medicines highlights 2020 - infographic with figures

PDF iconHuman medicines highlights 2020

Previous highlights:

PDF iconHuman medicines highlights 2019  

PDF iconHuman medicines highlights 2018

PDF iconHuman medicines highlights 2017

PDF iconHuman medicines highlights 2016

PDF iconHuman medicines highlights 2015

PDF iconVeterinary medicine highlights 2020

Previous highlights:

PDF iconVeterinary medicines highlights 2019

PDF iconVeterinary medicines highlights 2018

PDF iconVeterinary medicines highlights 2017

PDF iconVeterinary medicines highlights 2016

PDF iconVeterinary medicines highlights 2015

Monthly figures - 2020

Monthly figures - 2019

Monthly figures - 2018

Monthly figures - 2017

Monthly figures - 2016

Monthly figures archive (2007-2015)

Topics

Order